STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 66 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $148,000 | -11.9% | 30,635 | +73.3% | 0.00% | – |
| Q4 2018 | $168,000 | -90.2% | 17,675 | -82.9% | 0.00% | -100.0% |
| Q3 2018 | $1,720,000 | -45.1% | 103,614 | -46.9% | 0.00% | -50.0% |
| Q2 2018 | $3,134,000 | -18.2% | 195,292 | -22.0% | 0.00% | -20.0% |
| Q1 2018 | $3,831,000 | +27.4% | 250,421 | +29.9% | 0.01% | +25.0% |
| Q4 2017 | $3,008,000 | +210.4% | 192,833 | +120.9% | 0.00% | +300.0% |
| Q3 2017 | $969,000 | +3.0% | 87,294 | -14.7% | 0.00% | -50.0% |
| Q2 2017 | $941,000 | +718.3% | 102,284 | +657.5% | 0.00% | – |
| Q1 2017 | $115,000 | -65.6% | 13,502 | -56.8% | 0.00% | -100.0% |
| Q4 2016 | $334,000 | +7.7% | 31,257 | +9.1% | 0.00% | 0.0% |
| Q3 2016 | $310,000 | +37.2% | 28,646 | -14.3% | 0.00% | – |
| Q2 2016 | $226,000 | -2.2% | 33,440 | -32.6% | 0.00% | – |
| Q1 2016 | $231,000 | -31.0% | 49,597 | -6.5% | 0.00% | – |
| Q4 2015 | $335,000 | +131.0% | 53,029 | +329.7% | 0.00% | – |
| Q2 2015 | $145,000 | -66.4% | 12,342 | -43.9% | 0.00% | -100.0% |
| Q4 2013 | $431,000 | -69.8% | 22,002 | -30.2% | 0.00% | -50.0% |
| Q3 2013 | $1,428,000 | -22.4% | 31,534 | -59.1% | 0.00% | -33.3% |
| Q2 2013 | $1,840,000 | – | 77,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|